v3.26.1
Segment Reporting - Summary of Disaggregated Segment Expenses Split between R&D and G&A Costs (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]    
Research and development expenses $ 13,606 $ 23,888
General and administrative expenses 5,360 7,932
Loss from operations (18,966) (31,820)
Interest income 1,182 1,483
Interest expense (331) (406)
Other income (expense), net 188 (11)
Net loss (17,927) (30,754)
Operating Segments | Clinical and Development Costs    
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]    
Research and development expenses 8,280 10,537
Operating Segments | Preclinical Costs    
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]    
Research and development expenses (65) 1,238
Operating Segments | Personnel and Related Costs    
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]    
Research and development expenses 3,175 7,563
General and administrative expenses 1,841 2,825
Operating Segments | Stock-based Compensation Expense    
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]    
Research and development expenses 1,201 3,005
General and administrative expenses 1,308 2,211
Operating Segments | Other Research Costs    
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]    
Research and development expenses 1,015 1,545
Operating Segments | Other General and Administrative Costs    
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]    
General and administrative expenses $ 2,211 $ 2,896